BB BIOTECH VENTURES is a healthcare-dedicated venture capital fund, focused on companies that develop and market drugs and medical devices. The Guernsey–based fund is advised by the Bellevue Asset Management Group, which has operations in Curaçao, Boston/USA and Kusnacht/Zurich, Switzerland.
BB BIOTECH VENTURES has a dedicated team of investment advisors and an advisory board. In addition, it is supported by all of the Group’s health care investment experts, and an extensive network of specialists and advisors. Our goal is to maximize the returns to our investors. To achieve this goal, we combine hard working, experience, networking, and focus on value creation.
| Company | Date | Round | Size | Participants |
| Probiodrug | 11/09 | Series B | $54M | 8 |
| Palyon Medical | 5/09 | Series A | $21M | 5 |
| Orthocon | 4/09 | Series B | $25M | 3 |
| Aerovance | 4/09 | Unattributed | $38M | 8 |
